(Q44104885)

29 November 2017

title

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies (English)

1 reference

29 November 2017

0 references

1 reference

Patricia L Mottram

1

1 reference

29 November 2017

Lisa J Murray-Segal

2

1 reference

29 November 2017

Wenruo Han

3

1 reference

29 November 2017

Julie Maguire

4

1 reference

29 November 2017

Alicia N Stein-Oakley

5

1 reference

29 November 2017

publication date

1 June 2002

1 reference

29 November 2017

published in

Transplant Immunology

1 reference

29 November 2017

volume

10

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

63-72

1 reference

Genetic control of autoimmunity in type 1 diabetes

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Tolerance to islet autoantigens in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

The genetics and epidemiology of diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Diabetes results from a late change in the autoimmune response of NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Positive versus negative signaling by lymphocyte antigen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Autoimmune diabetes: the involvement of benign and malignant autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

B lymphocytes influence the shape of the mature preimmune CD4+ TCR repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Differential ability of T cell subsets to undergo activation-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2802%2900050-3

7 January 2021

10.1016/S0966-3274(02)00050-3

Identifiers

DOI

1 reference

release_d4ni6hv3w5azdahps7jb4t6kji

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4ni6hv3w5azdahps7jb4t6kji

24 November 2022

mapped directly with Wikidata item

1 reference